$1.5B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | SRRK Scholar Rock Hldg Corp | 4.3M | −52.5% | $237M | 15.9% |
| 2 | KRYS Krystal Biotech Inc | 632,005 | −6.2% | $235M | 15.8% |
| 3 | STOK Stoke Therapeutics Inc | 3.9M | −5.2% | $129M | 8.7% |
| 4 | IMNM Immunome Inc | 4.9M | −11.6% | $104M | 7.0% |
| 5 | NRIX Nurix Therapeutics Inc | 4.1M | −47.3% | $99M | 6.6% |
| 6 | ABSI Absci Corporation | 6.7M | −18.3% | $78M | 5.2% |
| 7 | ANNX Annexon Inc | 11.9M | −18.4% | $68M | 4.6% |
| 8 | RGNX Regenxbio Inc | 4.4M | +0.0% | $52M | 3.5% |
| 9 | STTK Shattuck Labs Inc | 6.9M | +24.4% | $48M | 3.2% |
| 10 | NGNE Neurogene Inc | 1.4M | −3.2% | $44M | 3.0% |
| 11 | BEAM Beam Therapeutics Inc | 1.2M | −5.9% | $40M | 2.7% |
| 12 | AGMB Agomab Therapeutics Nv | 2.7M | +1649.7% | $35M | 2.4% |
| 13 | FATE Fate Therapeutics Inc | 12.9M | +0.0% | $35M | 2.3% |
| 14 | IDYA Ideaya Biosciences Inc | 640,202 | +22.9% | $24M | 1.6% |
| 15 | SLN Silence Therapeutics Plc | 2.2M | +0.0% | $24M | 1.6% |
| 16 | COGT Cogent Biosciences Inc | 503,321 | −26.8% | $19M | 1.3% |
| 17 | SLDB Solid Biosciences Inc | 1.9M | −3.1% | $19M | 1.3% |
| 18 | NUVB Nuvation Bio Inc | 3.0M | −3.9% | $17M | 1.2% |
| 19 | CLDX Celldex Therapeutics Inc New | 433,921 | +65.9% | $16M | 1.1% |
| 20 | CLYM Climb Bio Inc | 1.2M | — | $16M | 1.1% |
| 21 | ALXO Alx Oncology Hldgs Inc | 7.4M | −7.2% | $15M | 1.0% |
| 22 | BMRN Biomarin Pharmaceutical Inc | 265,169 | +52.5% | $15M | 1.0% |
| 23 | XENE Xenon Pharmaceuticals Inc | 229,374 | −12.7% | $14M | 0.9% |
| 24 | ZYME Zymeworks Inc | 491,654 | +0.0% | $13M | 0.9% |
| 25 | ADCT Adc Therapeutics Sa | 11.5M | −25.5% | $12M | 0.8% |
| 26 | AURA Aura Biosciences Inc | 1.7M | — | $12M | 0.8% |
| 27 | ODTX Odyssey Therapeutics Inc | 425,000 | — | $8M | 0.5% |
| 28 | LIVN Livanova Plc | 93,154 | −14.0% | $8M | 0.5% |
| 29 | ESTA Establishment Labs Hldgs Inc | 88,964 | −14.0% | $8M | 0.5% |
| 30 | CBLL Ceribell Inc | 386,786 | +0.0% | $8M | 0.5% |
| 31 | DBVT Dbv Technologies S A | 410,440 | −16.5% | $7M | 0.5% |
| 32 | INSM Insmed Inc | 51,234 | — | $5M | 0.4% |
| 33 | PRME Prime Medicine Inc | 1.4M | −12.6% | $5M | 0.3% |
| 34 | ATRA Atara Biotherapeutics Inc | 441,701 | +0.0% | $5M | 0.3% |
| 35 | EPRX Eupraxia Pharmaceuticals Inc | 611,400 | −12.7% | $4M | 0.3% |
| 36 | ORIC Oric Pharmaceuticals Inc | 362,010 | −12.9% | $4M | 0.3% |
| 37 | ARDX Ardelyx Inc | 641,750 | −12.5% | $3M | 0.2% |
| 38 | IVVD Invivyd Inc | 2.6M | −1.9% | $2M | 0.2% |
| 39 | PLRX Pliant Therapeutics Inc | 772,126 | +0.0% | $880,224 | 0.1% |